Diphthamide modification of eEF2 is required for gut tumor‐like hyperplasia induced by oncogenic Ras

Eukaryotic elongation factor 2 (eEF2) undergoes a unique post‐translational modification called diphthamidation. Although eEF2 diphthamidation is highly conserved, its pathophysiological function is still largely unknown. To elucidate the function of diphthamidation in tumor, we examined the involve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Genes to cells : devoted to molecular & cellular mechanisms 2020-02, Vol.25 (2), p.76-85
Hauptverfasser: Tsuda‐Sakurai, Kayoko, Kimura, Masaki, Miura, Masayuki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 85
container_issue 2
container_start_page 76
container_title Genes to cells : devoted to molecular & cellular mechanisms
container_volume 25
creator Tsuda‐Sakurai, Kayoko
Kimura, Masaki
Miura, Masayuki
description Eukaryotic elongation factor 2 (eEF2) undergoes a unique post‐translational modification called diphthamidation. Although eEF2 diphthamidation is highly conserved, its pathophysiological function is still largely unknown. To elucidate the function of diphthamidation in tumor, we examined the involvement of diphthamidation pathway enzyme Dph5 in tumor progression in Drosophila adult gut. Expression of oncogenic RasV12 in gut intestinal stem cells (ISCs) and enteroblasts (EBs) causes hypertrophy and disruption of gut epithelia, and shortened life span. Knockdown of Dph5 ameliorated these pathogenic phenotypes. Dph5 is required for gross translation activation and high dMyc protein level in RasV12 tumor‐like hyperplasia. Transcriptome analysis revealed that Dph5 is involved in the regulation of ribosome biogenesis genes. These results suggest that diphthamidation is required for translation activation partly through the regulation of ribosome biogenesis in Ras‐induced tumor‐like hyperplasia model in Drosophila gut. Expression of oncogenic RasV12 in gut intestinal stem cells (ISCs) and enteroblasts (EBs) causes hypertrophy and disruption of gut epithelia and shortened life span. Knockdown of Dph5 ameliorated these pathogenic phenotypes.
doi_str_mv 10.1111/gtc.12742
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2325299573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2325299573</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4542-9ea943408dc3148dc84665a355a6883bbdbc8bf6a1c3197d1700c64295ed2a6e3</originalsourceid><addsrcrecordid>eNp10MtKxDAUBuAgiveFLyABN7qo09zaZinjFQRBdF3S5HQm2jY1aZHZ-Qg-o09ixlEXglmcBPLxc_gROiDpKYlnMhv0KaE5p2tom7BMJJRztr58iyyRQuZbaCeEpzQljKZiE20xUtCikPk2qs9tPx_mqrUGcOuMra1Wg3UddjWGi0uKbcAeXkbrweDaeTwbBzyMrfMfb--NfQY8X_Tg-0YFq7DtzKgjrBbYddrNoLMa36uwhzZq1QTY_7530ePlxcP0Orm9u7qZnt0mmgtOEwlKcsbTwmhGeJwFzzKhmBAqKwpWVabSRVVnisR_mRuSp6nOOJUCDFUZsF10vMrtvXsZIQxla4OGplEduDGUlFFBpRQ5i_ToD31yo-_idlFFRKTMaVQnK6W9C8FDXfbetsovSpKWy_LLWH75VX60h9-JY9WC-ZU_bUcwWYFX28Di_6Ty6mG6ivwEV2qOWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2352919972</pqid></control><display><type>article</type><title>Diphthamide modification of eEF2 is required for gut tumor‐like hyperplasia induced by oncogenic Ras</title><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><creator>Tsuda‐Sakurai, Kayoko ; Kimura, Masaki ; Miura, Masayuki</creator><creatorcontrib>Tsuda‐Sakurai, Kayoko ; Kimura, Masaki ; Miura, Masayuki</creatorcontrib><description>Eukaryotic elongation factor 2 (eEF2) undergoes a unique post‐translational modification called diphthamidation. Although eEF2 diphthamidation is highly conserved, its pathophysiological function is still largely unknown. To elucidate the function of diphthamidation in tumor, we examined the involvement of diphthamidation pathway enzyme Dph5 in tumor progression in Drosophila adult gut. Expression of oncogenic RasV12 in gut intestinal stem cells (ISCs) and enteroblasts (EBs) causes hypertrophy and disruption of gut epithelia, and shortened life span. Knockdown of Dph5 ameliorated these pathogenic phenotypes. Dph5 is required for gross translation activation and high dMyc protein level in RasV12 tumor‐like hyperplasia. Transcriptome analysis revealed that Dph5 is involved in the regulation of ribosome biogenesis genes. These results suggest that diphthamidation is required for translation activation partly through the regulation of ribosome biogenesis in Ras‐induced tumor‐like hyperplasia model in Drosophila gut. Expression of oncogenic RasV12 in gut intestinal stem cells (ISCs) and enteroblasts (EBs) causes hypertrophy and disruption of gut epithelia and shortened life span. Knockdown of Dph5 ameliorated these pathogenic phenotypes.</description><identifier>ISSN: 1356-9597</identifier><identifier>EISSN: 1365-2443</identifier><identifier>DOI: 10.1111/gtc.12742</identifier><identifier>PMID: 31828897</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Biosynthesis ; Digestive system ; diphthamidation ; Drosophila ; Gastrointestinal tract ; Gene expression ; Gene regulation ; Hyperplasia ; Hypertrophy ; Insects ; Intestine ; Life span ; Myc ; Phenotypes ; Ras ; Ras protein ; Stem cells ; Translation ; tumor</subject><ispartof>Genes to cells : devoted to molecular &amp; cellular mechanisms, 2020-02, Vol.25 (2), p.76-85</ispartof><rights>2019 Molecular Biology Society of Japan and John Wiley &amp; Sons Australia, Ltd</rights><rights>2019 Molecular Biology Society of Japan and John Wiley &amp; Sons Australia, Ltd.</rights><rights>2020 Molecular Biology Society of Japan and John Wiley &amp; Sons Australia, Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4542-9ea943408dc3148dc84665a355a6883bbdbc8bf6a1c3197d1700c64295ed2a6e3</citedby><cites>FETCH-LOGICAL-c4542-9ea943408dc3148dc84665a355a6883bbdbc8bf6a1c3197d1700c64295ed2a6e3</cites><orcidid>0000-0001-7444-5705</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fgtc.12742$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fgtc.12742$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,1432,27923,27924,45573,45574,46408,46832</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31828897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tsuda‐Sakurai, Kayoko</creatorcontrib><creatorcontrib>Kimura, Masaki</creatorcontrib><creatorcontrib>Miura, Masayuki</creatorcontrib><title>Diphthamide modification of eEF2 is required for gut tumor‐like hyperplasia induced by oncogenic Ras</title><title>Genes to cells : devoted to molecular &amp; cellular mechanisms</title><addtitle>Genes Cells</addtitle><description>Eukaryotic elongation factor 2 (eEF2) undergoes a unique post‐translational modification called diphthamidation. Although eEF2 diphthamidation is highly conserved, its pathophysiological function is still largely unknown. To elucidate the function of diphthamidation in tumor, we examined the involvement of diphthamidation pathway enzyme Dph5 in tumor progression in Drosophila adult gut. Expression of oncogenic RasV12 in gut intestinal stem cells (ISCs) and enteroblasts (EBs) causes hypertrophy and disruption of gut epithelia, and shortened life span. Knockdown of Dph5 ameliorated these pathogenic phenotypes. Dph5 is required for gross translation activation and high dMyc protein level in RasV12 tumor‐like hyperplasia. Transcriptome analysis revealed that Dph5 is involved in the regulation of ribosome biogenesis genes. These results suggest that diphthamidation is required for translation activation partly through the regulation of ribosome biogenesis in Ras‐induced tumor‐like hyperplasia model in Drosophila gut. Expression of oncogenic RasV12 in gut intestinal stem cells (ISCs) and enteroblasts (EBs) causes hypertrophy and disruption of gut epithelia and shortened life span. Knockdown of Dph5 ameliorated these pathogenic phenotypes.</description><subject>Biosynthesis</subject><subject>Digestive system</subject><subject>diphthamidation</subject><subject>Drosophila</subject><subject>Gastrointestinal tract</subject><subject>Gene expression</subject><subject>Gene regulation</subject><subject>Hyperplasia</subject><subject>Hypertrophy</subject><subject>Insects</subject><subject>Intestine</subject><subject>Life span</subject><subject>Myc</subject><subject>Phenotypes</subject><subject>Ras</subject><subject>Ras protein</subject><subject>Stem cells</subject><subject>Translation</subject><subject>tumor</subject><issn>1356-9597</issn><issn>1365-2443</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp10MtKxDAUBuAgiveFLyABN7qo09zaZinjFQRBdF3S5HQm2jY1aZHZ-Qg-o09ixlEXglmcBPLxc_gROiDpKYlnMhv0KaE5p2tom7BMJJRztr58iyyRQuZbaCeEpzQljKZiE20xUtCikPk2qs9tPx_mqrUGcOuMra1Wg3UddjWGi0uKbcAeXkbrweDaeTwbBzyMrfMfb--NfQY8X_Tg-0YFq7DtzKgjrBbYddrNoLMa36uwhzZq1QTY_7530ePlxcP0Orm9u7qZnt0mmgtOEwlKcsbTwmhGeJwFzzKhmBAqKwpWVabSRVVnisR_mRuSp6nOOJUCDFUZsF10vMrtvXsZIQxla4OGplEduDGUlFFBpRQ5i_ToD31yo-_idlFFRKTMaVQnK6W9C8FDXfbetsovSpKWy_LLWH75VX60h9-JY9WC-ZU_bUcwWYFX28Di_6Ty6mG6ivwEV2qOWQ</recordid><startdate>202002</startdate><enddate>202002</enddate><creator>Tsuda‐Sakurai, Kayoko</creator><creator>Kimura, Masaki</creator><creator>Miura, Masayuki</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7444-5705</orcidid></search><sort><creationdate>202002</creationdate><title>Diphthamide modification of eEF2 is required for gut tumor‐like hyperplasia induced by oncogenic Ras</title><author>Tsuda‐Sakurai, Kayoko ; Kimura, Masaki ; Miura, Masayuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4542-9ea943408dc3148dc84665a355a6883bbdbc8bf6a1c3197d1700c64295ed2a6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Biosynthesis</topic><topic>Digestive system</topic><topic>diphthamidation</topic><topic>Drosophila</topic><topic>Gastrointestinal tract</topic><topic>Gene expression</topic><topic>Gene regulation</topic><topic>Hyperplasia</topic><topic>Hypertrophy</topic><topic>Insects</topic><topic>Intestine</topic><topic>Life span</topic><topic>Myc</topic><topic>Phenotypes</topic><topic>Ras</topic><topic>Ras protein</topic><topic>Stem cells</topic><topic>Translation</topic><topic>tumor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsuda‐Sakurai, Kayoko</creatorcontrib><creatorcontrib>Kimura, Masaki</creatorcontrib><creatorcontrib>Miura, Masayuki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Genes to cells : devoted to molecular &amp; cellular mechanisms</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsuda‐Sakurai, Kayoko</au><au>Kimura, Masaki</au><au>Miura, Masayuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diphthamide modification of eEF2 is required for gut tumor‐like hyperplasia induced by oncogenic Ras</atitle><jtitle>Genes to cells : devoted to molecular &amp; cellular mechanisms</jtitle><addtitle>Genes Cells</addtitle><date>2020-02</date><risdate>2020</risdate><volume>25</volume><issue>2</issue><spage>76</spage><epage>85</epage><pages>76-85</pages><issn>1356-9597</issn><eissn>1365-2443</eissn><abstract>Eukaryotic elongation factor 2 (eEF2) undergoes a unique post‐translational modification called diphthamidation. Although eEF2 diphthamidation is highly conserved, its pathophysiological function is still largely unknown. To elucidate the function of diphthamidation in tumor, we examined the involvement of diphthamidation pathway enzyme Dph5 in tumor progression in Drosophila adult gut. Expression of oncogenic RasV12 in gut intestinal stem cells (ISCs) and enteroblasts (EBs) causes hypertrophy and disruption of gut epithelia, and shortened life span. Knockdown of Dph5 ameliorated these pathogenic phenotypes. Dph5 is required for gross translation activation and high dMyc protein level in RasV12 tumor‐like hyperplasia. Transcriptome analysis revealed that Dph5 is involved in the regulation of ribosome biogenesis genes. These results suggest that diphthamidation is required for translation activation partly through the regulation of ribosome biogenesis in Ras‐induced tumor‐like hyperplasia model in Drosophila gut. Expression of oncogenic RasV12 in gut intestinal stem cells (ISCs) and enteroblasts (EBs) causes hypertrophy and disruption of gut epithelia and shortened life span. Knockdown of Dph5 ameliorated these pathogenic phenotypes.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31828897</pmid><doi>10.1111/gtc.12742</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-7444-5705</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1356-9597
ispartof Genes to cells : devoted to molecular & cellular mechanisms, 2020-02, Vol.25 (2), p.76-85
issn 1356-9597
1365-2443
language eng
recordid cdi_proquest_miscellaneous_2325299573
source Wiley Free Content; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals
subjects Biosynthesis
Digestive system
diphthamidation
Drosophila
Gastrointestinal tract
Gene expression
Gene regulation
Hyperplasia
Hypertrophy
Insects
Intestine
Life span
Myc
Phenotypes
Ras
Ras protein
Stem cells
Translation
tumor
title Diphthamide modification of eEF2 is required for gut tumor‐like hyperplasia induced by oncogenic Ras
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T05%3A29%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diphthamide%20modification%20of%20eEF2%20is%20required%20for%20gut%20tumor%E2%80%90like%20hyperplasia%20induced%20by%20oncogenic%20Ras&rft.jtitle=Genes%20to%20cells%20:%20devoted%20to%20molecular%20&%20cellular%20mechanisms&rft.au=Tsuda%E2%80%90Sakurai,%20Kayoko&rft.date=2020-02&rft.volume=25&rft.issue=2&rft.spage=76&rft.epage=85&rft.pages=76-85&rft.issn=1356-9597&rft.eissn=1365-2443&rft_id=info:doi/10.1111/gtc.12742&rft_dat=%3Cproquest_cross%3E2325299573%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2352919972&rft_id=info:pmid/31828897&rfr_iscdi=true